Defective B cell tolerance checkpoints in systemic lupus erythematosus

A cardinal feature of systemic lupus erythematosus (SLE) is the development of autoantibodies. The first autoantibodies described in patients with SLE were those specific for nuclei and DNA, but subsequent work has shown that individuals with this disease produce a panoply of different autoantibodies. Thus, one of the constant features of SLE is a profound breakdown in tolerance in the antibody system. The appearance of self-reactive antibodies in SLE precedes clinical disease, but where in the B cell pathway tolerance is first broken has not been defined. In healthy humans, autoantibodies are removed from the B cell repertoire in two discrete early checkpoints in B cell development. We found these checkpoints to be defective in three adolescent patients with SLE. 25–50% of the mature naive B cells in SLE patients produce self-reactive antibodies even before they participate in immune responses as compared with 5–20% in controls. We conclude that SLE is associated with abnormal early B cell tolerance.

[1]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[2]  V. Poindron,et al.  Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. , 2004, Blood.

[3]  S. Tangye,et al.  The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. , 2004, Current opinion in pharmacology.

[4]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[5]  J. Cyster,et al.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. , 2004, Immunity.

[6]  M. Nussenzweig,et al.  Surrogate Light Chain Expressing Human Peripheral B Cells Produce Self-reactive Antibodies , 2004, The Journal of experimental medicine.

[7]  S. Liossis,et al.  B Lymphocyte Selection and Survival in Systemic Lupus , 2004, International Archives of Allergy and Immunology.

[8]  M. Shlomchik,et al.  Activation of autoreactive B cells by CpG dsDNA. , 2003, Immunity.

[9]  C. Goodnow,et al.  Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling , 2003, Nature Immunology.

[10]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[11]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[12]  M. Radic,et al.  Regulation of anti-phosphatidylserine antibodies. , 2003, Immunity.

[13]  N. Brot,et al.  I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement Activation , 2002, The Journal of experimental medicine.

[14]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[15]  P. Lipsky,et al.  Immunoglobulin variable-region gene usage in systemic autoimmune diseases. , 2001, Arthritis and rheumatism.

[16]  M. Carroll,et al.  Innate immunity in the etiopathology of autoimmunity , 2001, Nature Immunology.

[17]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[18]  A. Cappione,et al.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.

[19]  M. Nussenzweig,et al.  Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. , 2001, The Journal of clinical investigation.

[20]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.

[21]  P. Lipsky.  Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity , 2001, Nature Immunology.

[22]  I. Aguilera,et al.  Molecular structure of eight human autoreactive monoclonal antibodies , 2001, Immunology.

[23]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[24]  J. V. Ravetch,et al.  IgG Fc receptors. , 2001, Annual review of immunology.

[25]  P. Lipsky,et al.  Enhanced Mutational Activity and Disturbed Selection of Mutations in VH Gene Rearrangements in a Patient with Systemic Lupus Erythematosus , 2001, Autoimmunity.

[26]  P. Lipsky,et al.  Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.

[27]  P. Lipsky,et al.  Use of Immunoglobulin Variable-Region Genes by Normal Subjects and Patients with Systemic Lupus Erythematosus , 2000, International Archives of Allergy and Immunology.

[28]  J. Monroe,et al.  Immunobiology of the immature B cell: plasticity in the B‐cell antigen receptor‐induced response fine tunes negative selection , 2000, Immunological reviews.

[29]  A. Rolink,et al.  Repertoire selection by pre‐B‐cell receptors and B‐cell receptors, and genetic control of B‐cell development from immature to mature B cells , 2000, Immunological reviews.

[30]  M. Walport.  Lupus, DNase and defective disposal of cellular debris , 2000, Nature Genetics.

[31]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[32]  D. Lacey,et al.  Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Janeway,et al.  A B-cell receptor-specific selection step governs immature to mature B cell differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Diamond,et al.  Autoimmune diseases , 2000, Bone Marrow Transplantation.

[35]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[36]  P. Lipsky,et al.  Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus. , 1999, Clinical immunology.

[37]  P. Lipsky,et al.  Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. , 1999, Journal of immunology.

[38]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[39]  F. E. Bertrand,et al.  IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth. , 1999, Journal of immunology.

[40]  S. Tangye,et al.  Identification of Functional Human Splenic Memory B Cells by Expression of CD148 and CD27 , 1998, The Journal of experimental medicine.

[41]  K. Rajewsky,et al.  Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.

[42]  P. Lipsky,et al.  Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. , 1998, The Journal of clinical investigation.

[43]  D. Mevorach,et al.  Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production , 1998, The Journal of experimental medicine.

[44]  B. Diamond,et al.  Lupus-specific antibodies reveal an altered pattern of somatic mutation. , 1997, The Journal of clinical investigation.

[45]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[46]  N. Suzuki,et al.  Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus. , 1996, The Journal of clinical investigation.

[47]  K. Rajewsky.  Clonal selection and learning in the antibody system , 1996, Nature.

[48]  T. Martin,et al.  Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. , 1995, Journal of immunology.

[49]  J. Cyster,et al.  Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire , 1994, Nature.

[50]  P. Casali,et al.  Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments , 1994, The Journal of experimental medicine.

[51]  P. Chastagner,et al.  Human lupus anti‐DNA autoantibodies undergo essentially primary V kappa gene rearrangements. , 1994, The EMBO journal.

[52]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[53]  A. Basten,et al.  Reduced life span of anergic self-reactive B cells in a double- transgenic model , 1994, The Journal of experimental medicine.

[54]  W. Anderson,et al.  Residues that mediate DNA binding of autoimmune antibodies. , 1993, Journal of immunology.

[55]  S. Camper,et al.  Receptor editing: an approach by autoreactive B cells to escape tolerance , 1993, The Journal of experimental medicine.

[56]  D. Nemazee,et al.  Receptor editing in self-reactive bone marrow B cells , 1993, The Journal of experimental medicine.

[57]  J. Ledbetter,et al.  Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein. , 1992, Blood.

[58]  G. Morahan,et al.  Peripheral deletion of self-reactive B cells , 1991, Nature.

[59]  K. Rajewsky,et al.  Most peripheral B cells in mice are ligand selected , 1991, The Journal of experimental medicine.

[60]  D. Nemazee,et al.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.

[61]  E. Tan,et al.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.

[62]  S. Smith‐Gill,et al.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.

[63]  M. Cygler,et al.  Antibodies to DNA , 1988, BioEssays : news and reviews in molecular, cellular and developmental biology.

[64]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Thomas L. Rothstein,et al.  The role of clonal selection and somatic mutation in autoimmunity , 1987, Nature.

[66]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[67]  I. Mackay,et al.  Autoimmune diseases. , 1981, Scientific American.

[68]  G. Miller,et al.  A new complement function: solubilization of antigen-antibody aggregates. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H. Holman,et al.  Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. , 1957, Science.